Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Events & presentations
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
21 Jun 2015 - 24 Jun 2015
EUNOS, 21-24 June, 2015, Ljubljana, Slovenia
15 Jun 2015 - 17 Jun 2015
BIO, June 15-17, 2015, Philadelphia (PA)
05 Jun 2015 - 07 Jun 2015
Mitocon, June 5-7, 2015, Bologna, Italy
03 May 2015 - 07 May 2015
ARVO, May 3-7, 2015, Denver, Colorado
22 Apr 2015 - 24 Apr 2015
April 22-24, 2015: GenSight will present at the World Orphan Drug Congress
12 Mar 2015
March 12, 2015: GenSight participated at the 5th Annual Advanced Therapies Summit,
09 Mar 2015 - 11 Mar 2015
March 9-11, 2015: GenSight attended BioEurope Spring, Paris.
21 Feb 2015 - 26 Feb 2015
February 21-26, 2015: Â GenSight attended NANOS
12 Jan 2015 - 16 Jan 2015
January 12-16, 2015: GenSight presented at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco (CA),
03 Dec 2014
December 3, 2014: Didier Pruneau, CSO of GenSight, featured at Gene Therapy
View previous 9 articles
1
…
10
11
12
13
14
15
16
17
View next 9 articles
Go back to the page of the page